(Q34034500)

30 July 2017

Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors (English)

1 reference

30 July 2017

0 references

6

H A Katus

1 reference

30 July 2017

K Varadi

1

1 reference

30 July 2017

S Michelfelder

2

1 reference

30 July 2017

T Korff

3

1 reference

30 July 2017

M Hecker

4

1 reference

30 July 2017

M Trepel

5

1 reference

30 July 2017

J A Kleinschmidt

7

1 reference

30 July 2017

O J Müller

8

1 reference

30 July 2017

29 September 2011

1 reference

30 July 2017

1 reference

30 July 2017

19

1 reference

30 July 2017

8

1 reference

30 July 2017

800-809

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2011.143

30 July 2017

0 references

cites work

Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Adenovirus-mediated overexpression of glutathione-s-transferase mitigates transplant arteriosclerosis in rabbit carotid allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Isolation of targeted AAV2 vectors from novel virus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Engineering adeno-associated virus 2 vectors for targeted gene delivery to atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Construction of diverse adeno-associated viral libraries for directed evolution of enhanced gene delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Identification of a heparin-binding motif on adeno-associated virus type 2 capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Clades of Adeno-associated viruses are widely disseminated in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Immune responses to gene therapy vectors: influence on vector function and effector mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

RGD and other recognition sequences for integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Production and purification of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Novel tools for production and purification of recombinant adenoassociated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

inferred from DOI database lookup

7 January 2021

based on heuristic

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.143

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.143

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference